BRIGHT and LanzaTech partner on carbon conversion biotechnology in Europe
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St rises as AI momentum holds heading into key earnings, Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- S&P Global explores potential separation of Capital IQ business
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- Equities end higher as Anthropic's IPO filing buoys AI stocks
BRIGHT and LanzaTech launch new partnership to accelerate carbon-to-value biotechnology in Europe
May 6, 2026 10:21 AM EDTCOPENHAGEN, Denmark, May 06, 2026 (GLOBE NEWSWIRE) -- BRIGHT, the Novo Nordisk Foundation Biotechnology Research Institute for the Green Transition at the Technical University of Denmark (DTU) and LanzaTech Global, Inc. (NASDAQ:Â LNZA) (LanzaTech), a global leader in gas fermentation, have entered a multi-year agreement to accelerate development of technologies that convert carbon emissions into valuable products.
The partnership runs until April 2028 and... More



